HEMARTHROSIS IN PATIENTS WITH ACQUIRED FACTOR-VIII INHIBITOR

被引：0
|
作者：
LOUTHRENOO, W
ABRAHM, J
SCHUMACHER, HR
机构：
[1] VET ADM MED CTR,CTR ARTHRITIS IMMUNOL,PHILADELPHIA,PA 19104
[2] VET ADM MED CTR,HEMATOL ONCOL SECT,PHILADELPHIA,PA 19104
[3] UNIV PENN,SCH MED,DEPT MED,PHILADELPHIA,PA 19104
来源：
JOURNAL OF RHEUMATOLOGY | 1991年 / 18卷 / 01期
关键词：
HEMARTHROSIS; FACTOR-VIII INHIBITOR; CIRCULATING ANTICOAGULANT;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We describe 2 patients who presented with hemarthrosis and were found to have an underlying Factor VIII inhibitor. One case was associated with a renal cell carcinoma. Factor VIII inhibitor should be included in the differential diagnostic lists of causes of hemarthrosis.
引用
收藏
页码：104 / 105
页数：2
相关论文
共 50 条
  • [41] Acquired factor VIII inhibitor and subsequent development of non-Hodgkin's lymphoma: a case report and review of the literature
    Porru, Mariagrazia
    Mameli, Antonella
    Cianchetti, Elisabetta M.
    Musu, Mario
    Montisci, Roberto
    Finco, Gabriele
    Marongiu, Francesco
    BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (08) : 967 - 971
  • [42] ACQUIRED FACTOR VIII-C INHIBITOR IN A PATIENT WITH SJOGRENS-SYNDROME - SUCCESSFUL TREATMENT WITH STEROID AND IMMUNOSUPPRESSIVE THERAPY
    DANNHAUSER, D
    CASONATO, A
    PIETROGRANDE, F
    PONTARA, E
    BERTOMORO, A
    ZERBINATI, P
    GIROLAMI, A
    ACTA HAEMATOLOGICA, 1994, 91 (02) : 73 - 76
  • [43] Acquired hemophilia A caused by factor VIII inhibitors: report of a case
    Yoshinori Hosoya
    Miho Matsumura
    Seiji Madoiwa
    Toru Zuiki
    Shiro Matsumoto
    Shin Nunomiya
    Alan Lefor
    Naohiro Sata
    Yoshikazu Yasuda
    Surgery Today, 2013, 43 : 670 - 674
  • [44] Acquired hemophilia A caused by factor VIII inhibitors: report of a case
    Hosoya, Yoshinori
    Matsumura, Miho
    Madoiwa, Seiji
    Zuiki, Toru
    Matsumoto, Shiro
    Nunomiya, Shin
    Lefor, Alan
    Sata, Naohiro
    Yasuda, Yoshikazu
    SURGERY TODAY, 2013, 43 (06) : 670 - 674
  • [45] Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature
    Jameel Muzaffar
    Lakshmikanth Katragadda
    Sajjad Haider
    Ali Javed
    Elias Anaissie
    Saad Usmani
    International Journal of Hematology, 2012, 95 : 102 - 106
  • [46] "Accessory After the Factors": A Rare Case of an Acquired Factor VIII Inhibitor in a 75-Year-Old Man on Rivaroxaban
    Gutierrez, Nikolas
    Park, James
    Leighton, Terrance
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [47] Successful elimination of factor VIII inhibitor using cyclosporin A
    Maclean, PS
    Tait, RC
    Lowe, GDO
    Walker, ID
    McColl, MD
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (06) : 1024 - 1025
  • [48] A close insight to factor VIII inhibitor in the congenital hemophilia A
    Tabriznia-Tabrizi, Shamsoreza
    Gholampour, Marzie
    Mansouritorghabeh, Hassan
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (09) : 903 - 913
  • [49] Improving the performance of factor VIII inhibitor tests in hemophilia A
    Miller, Connie H.
    THROMBOSIS RESEARCH, 2015, 136 (06) : 1047 - 1048
  • [50] Acquired Factor VIII Inhibitor as Initial Manifestation of Collagen Vascular Disease: Response to Combination Immunosuppression as First-Line Therapy
    Wilson, Bethany
    Means, Robert T., Jr.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 342 (01) : 70 - 72
12345